Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient
2022 · Frontiers in Immunology · 9 citations
https://doi.org/10.3389/fimmu.2021.784861
L
Li Luo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
173
Citations
8
h-index
6
i10-index
Li Luo is an academic researcher from BGI Group (China). The author has contributed to research in topics: Colorectal Cancer Surgical Treatments & Gastric Cancer Management and Outcomes & Colorectal Cancer Treatments and Studies. The author has an h-index of 8, co-authored 34 publications.
Papers by this author
worksAnalysis of Tryptophan Metabolic Profile Characteristics and Clinical Value in Differentiated Thyroid Cancer Patients
2025 · Cancer Medicine · 2 citations
https://doi.org/10.1002/cam4.70808
3′-Daidzein Sulfonate Sodium Protects against Glutamate-induced NeuronalInjuries by Regulating NMDA Receptors
2024 · Current Pharmaceutical Design · 1 citations
https://doi.org/10.2174/0113816128299123240505172222
Genetic characterisation for Yan’an Han population in Northern Shaanxi Province, China, via 38Y-STRs using Yfiler™ Platinum
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.15052368
Additional file 1 of Application of logistic differential equation models for early warning of infectious diseases in Jilin Province
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21505525
Genomic evolution and stability of the mcr-1-harboring IncI2 plasmid in the presence and absence of colistin
2025 · BMC Genomics · 0 citations
https://doi.org/10.1186/s12864-025-12325-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat